Molly Harper - Dec 15, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Molly Harper
Stock symbol
CPRX
Transactions as of
Dec 15, 2023
Transactions value $
-$143,620
Form type
4
Date filed
12/19/2023, 05:00 PM
Previous filing
Dec 12, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale -$57.7K -4K -100% $14.43 0 Dec 15, 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $57.8K +10K $5.78 10K Dec 15, 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$144K -10K -100% $14.37 0 Dec 15, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -10K -7.1% $0.00 131K Dec 15, 2023 Common Stock 10K $5.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $14.37 to $14.40 per share.
F3 Options vest in three annual tranches beginning on June 29, 2022.